elvn-002
·Code: ELVN-002
elvn-002: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Enliven Therapeutics, Inc. (ELVN) | Phase 1 |
Clinical Trials (1)
A Phase 1a/1b Study of ELVN-002 for the Treatment of Patients With HER2 Mutant Non-Small Cell Lung Cancer
Frequently asked questions
Who is developing elvn-002?
elvn-002 is being developed by Enliven Therapeutics, Inc..
How many clinical trials involve elvn-002?
BioSniper tracks 1 clinical trial involving elvn-002.
Get deeper analysis on elvn-002
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis